Portfolio Companies
New companies blossom from maturing PITCH projects. Together, these new companies create a portfolio with a history of support from PITCH. We represent them here.
Inhibitors of novel phosphatases as anti-fibrotic therapeutics
Combating cancer with medicine and radiation
Developing a platform technology to target a universal biomarker of solid tumors
Developing novel antibacterial agents to fight bacterial infections
A novel antibody therapy for Inflammatory Bowel Disease
Identifying a novel therapy to combat antifungal infections
Targeting a metabolic kinase for antifungal therapy
Activating the host innately to combat viral infections
Restoring barrier function as a treatment for colitis
Selective Lipid Kinase Inhibitors as Novel Agents for the Treatment of Cancer
Identifying small molecule inhibitors of an epigenetic target to treat cancer
Identifying small molecule modulators of an epigenetic regulator for cancer therapy
Delivering toxins to targets for cancer therapy
Identifying inhibitors of a viral target to treat Herpes family viruses
Stopping aggressive cancers in their tracks
Identifying substrate-selective inhibitors of a cancer driver
A new approach for T Cell lymphoma treatment
Optimizing a novel small molecule scaffold to block mechanisms of cancer cell survival